JBIO

15.4002.26%
BD

Bradford D. Dahms

CFO and Chief Business Officer

Mr. Bradford D. Dahms, also known as Brad, Ph.D, is Chief Financial Officer of Jade Biosciences, Inc. from July 1, 2025 and serves as its Chief Business Officer since 2026 and also served as its Treasurer since July 14, 2025 until 2026. He served as CFO & Chief Business Officer of IDRx, Inc. since March 2024. He was Chief Financial officer at Theseus Pharmaceuticals, Inc. since May 2021 and also served as Director and President from December 01, 2023 until February 14, 2024. He had been the Principal Financial Officer and Principal Accounting Officer at Selecta Biosciences, Inc. since September 3, 2019 until May 21, 2021. He had been the Chief Financial Officer at Selecta Biosciences, Inc. since September 03, 2019 until May 21, 2021. Mr. Dahms served as the Senior Vice President of the Healthcare Investment Banking at Cantor Fitzgerald & Co. from April 2014 to August 2019. He also served as an analyst at RBC Capital Markets from 2012 to 2014 and at JPMorgan Chase & Co. from 2010 to 2012. Mr. Dahms holds a Bachelor of Science degree in Economics, with honors, from The Ohio State University.

Positions